Prescribable VR therapy (DiGA) for children with ADHD.
| Date | Round | Amount |
|---|---|---|
| Apr 2026 | Seed Germany's brainjo closed a EUR 2M seed led by HTGF for clinical studies and regulatory approval of its VR therapy for childhood ADHD. | $2.3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.